AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...
European Commission approves GSK’s recombinant zoster vaccine, Shingrix in prefilled syringe: London, UK Thursday, January 8, 2026, 09:00 Hrs [IST] GSK plc announced the Europea ...
Additional challenges are exemplified by the very first mAb therapy, OKT3, which aimed to improve the survival rate of kidney transplant patients by modulating and transiently depleting effector T ...
SaltX Technology successfully completed dolomite testing in December at the company's research and development center (ECRC) in Hofors, Sweden. This is the first time dolomite has been tested at scale ...
ZettaJoule, Inc., an advanced small modular reactor company, today announced it has received formal support for its ZJ high-temperature gas-cooled reactor (HTGR) project from Aramco Services Company, ...
In recent years, recombinant collagen has become a key ingredient in both cosmetics and medical aesthetics. However, the cosmetics industry has questioned whether topical collagen can effectively ...
Fluid Quip Technologies (FQT), a leader in advanced processing and separation solutions for the biofuels industry, today announced that E Energy Adams in Adams, Nebraska, will implement FQT’s DCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback